Four important precautions and long-term monitoring guidelines for taking lipid-lowering medications.

Four Important Considerations for Lipid-Lowering Medications
Once patients with high blood lipids begin medication, they require long-term treatment, even lifelong medication.
To ensure efficacy, special attention should be paid to the following four aspects during medication:

Classification based on the risk of heart disease:
Lipid-lowering medications should be accurately classified according to the risk of heart disease. High-risk individuals are those who already have heart disease, or have a history of heart attack or stroke, or have peripheral vascular disease or diabetes. These individuals should use cholesterol-lowering medications; moderate-risk individuals are those with two or more risk factors for heart disease, such as hypertension, obesity, or smoking. Generally, moderate-risk individuals should also actively take medication; low-risk individuals are those with only one or no risk factors for heart disease. They should mainly adopt a balanced diet, increased exercise, and smoking cessation, and can temporarily refrain from taking medication.

Choosing the correct medication:
Lipid-lowering medications include statins, fibrates, and niacin. Statins are widely used and have a clear effect, suitable for patients with elevated cholesterol levels, especially low-density lipoprotein. Fibrates mainly target hypertriglyceridemia; niacin has a wide range of effects, lowering both triglycerides and low-density lipoprotein, and increasing high-density lipoprotein, suitable for mixed dyslipidemia. Each of the three types of drugs has its advantages, and each patient should choose the medication based on their specific lipid levels.

Reasonable drug dosage:
When taking lipid-lowering medications, do not rush for quick results, but take the medication within a safe dosage. In addition, combining lipid-lowering medications should be done with extreme caution. For example, combining statins and niacin significantly increases the risk of rhabdomyolysis. Always consult a doctor before taking medication to ensure rational drug use.

Do not stop medication on your own:
Many patients stop taking medication on their own once their lipid test results show "normal range." In fact, this is incorrect. On the one hand, the normal range of blood lipids indicated on the test report is only for healthy individuals, not for high-risk heart disease patients; on the other hand, even after blood lipids have dropped to the ideal range, patients still need to regularly monitor their blood lipid levels and adjust the drug dosage to keep blood lipid levels within the ideal range. If medication is stopped immediately after it starts to show effect, blood lipid levels may rise again. Taking lipid-lowering medications requires regular follow-up visits.
Clinical data shows that patients with dyslipidemia are highly susceptible to cardiovascular disease if they misuse their medication. Therefore, depending on the specific type of dyslipidemia, not only should the choice of lipid-lowering medication vary, but regular follow-up visits to the hospital are also necessary.

Adjusting medication dosage based on the condition
Since the onset and progression of dyslipidemia is a chronic process, patients with mild dyslipidemia generally experience no discomfort, while those with more severe cases may experience symptoms such as dizziness, headache, palpitations, difficulty speaking, and numbness in the limbs. Therefore, even if no discomfort is experienced after a period of lipid-lowering treatment, medication should not be stopped without consulting a doctor. Treatment for dyslipidemia generally requires long-term adherence to achieve significant results.

It is recommended that patients have their plasma cholesterol, triglycerides, and high-density lipoprotein cholesterol checked within 4-6 weeks of starting medication. Ideally, medication should be adjusted based on the test results and changes in lipid levels. If lipid levels do not reach the target level, the dosage should be increased, or a different lipid-lowering medication should be used, or combination therapy may be considered. If lipid levels have returned to normal or reached the target value after treatment, the original dosage should be continued, and the dosage should generally not be reduced unless lipid levels have dropped to very low levels.

Checking liver and kidney function every 3-6 months
If medication is taken continuously for a long period, the drugs may not be completely metabolized and absorbed by the body, potentially leading to toxic side effects and even drug poisoning.

The metabolic process of most drugs involves metabolism in the liver and then excretion through the kidneys. For long-term medication use, it is essential to have a check-up every 3-6 months. In addition to checking lipid levels, liver and kidney function and creatine kinase levels should also be checked to ensure that the drug's toxic side effects have not caused any damage to the liver and kidneys. Patients should also pay attention to the side effects and dosage of the medication, and avoid excessive lipid-lowering or trying to achieve results too quickly, as this may be counterproductive.